Literature DB >> 20649589

The neuronal nicotinic alpha4beta2 receptor has a high maximal probability of being open.

Ping Li1, Joe H Steinbach.   

Abstract

BACKGROUND AND
PURPOSE: A fundamental property of transmitter-gated ion channels is the probability a channel will be open (P(open)) when stimulated by a concentration of agonist that elicits a maximal response. This value is critical for interpreting steady-state concentration-response relationships in terms of channel activation, and for understanding the actions of drugs that potentiate responses. We used analysis of non-stationary noise to estimate the maximal probability the nicotinic alpha4beta2 receptor is open. EXPERIMENTAL APPROACH: HEK293 cells stably transfected to express human alpha4beta2 nicotinic receptors were studied using whole-cell voltage clamp. Nicotinic agonists (acetylcholine, nicotine, cytisine and 5-iodo A-85380) were applied, and the relationship between variance of the elicited whole-cell current and mean current was analysed. KEY
RESULTS: The variance did not increase linearly with the mean current. For acetylcholine and nicotine the relationship between variance and mean indicates that the maximal P(open) is greater than 0.8. The number of agonist-activatable channels was estimated to be about 1000 per cell. The mean single channel conductance at -60 mV was indistinguishable when currents were elicited by acetylcholine (18 pS), nicotine (17 pS) or 5-iodo A-85380 (17 pS), whereas the value for cytisine was larger (24 pS). CONCLUSIONS AND IMPLICATIONS: The neuronal nicotinic alpha4beta2 receptor has a maximal probability of being open that is greater than 0.8. This conclusion applies to the receptor containing three alpha4 and two beta2 subunits (the low-sensitivity stoichiometry), but may not apply to the receptor containing two alpha4 and three beta2 subunits (the high-sensitivity stoichiometry).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20649589      PMCID: PMC2958637          DOI: 10.1111/j.1476-5381.2010.00761.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

1.  Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine.

Authors:  C P Fenster; T L Whitworth; E B Sheffield; M W Quick; R A Lester
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

2.  Quantal release at a neuronal nicotinic synapse from rat adrenal gland.

Authors:  J G Barbara; K Takeda
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

3.  Ligand binding and activation of rat nicotinic alpha4beta2 receptors stably expressed in HEK293 cells.

Authors:  K Sabey; K Paradiso; J Zhang; J H Steinbach
Journal:  Mol Pharmacol       Date:  1999-01       Impact factor: 4.436

4.  Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function.

Authors:  B Buisson; D Bertrand
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

5.  Steroid inhibition of rat neuronal nicotinic alpha4beta2 receptors expressed in HEK 293 cells.

Authors:  K Paradiso; K Sabey; A S Evers; C F Zorumski; D F Covey; J H Steinbach
Journal:  Mol Pharmacol       Date:  2000-08       Impact factor: 4.436

6.  Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors.

Authors:  A Kuryatov; V Gerzanich; M Nelson; F Olale; J Lindstrom
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

7.  Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.

Authors:  Chantal J G M Smulders; Ruud Zwart; Isabel Bermudez; Regina G D M van Kleef; Paul J Groot-Kormelink; Henk P M Vijverberg
Journal:  Eur J Pharmacol       Date:  2005-02-21       Impact factor: 4.432

8.  The C terminus of the human nicotinic alpha4beta2 receptor forms a binding site required for potentiation by an estrogenic steroid.

Authors:  K Paradiso; J Zhang; J H Steinbach
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

9.  Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study.

Authors:  B Buisson; M Gopalakrishnan; S P Arneric; J P Sullivan; D Bertrand
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

10.  Synaptic transmission at visualized sympathetic boutons: stochastic interaction between acetylcholine and its receptors.

Authors:  M R Bennett; L Farnell; W G Gibson; N A Lavidis
Journal:  Biophys J       Date:  1997-04       Impact factor: 4.033

View more
  19 in total

1.  alpha4beta2 Nicotinic acetylcholine receptors, willing if able.

Authors:  Roger L Papke
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  A tale of ligands big and small: an update on how pentameric ligand-gated ion channels interact with agonists and proteins.

Authors:  Stephan A Pless; Lucia G Sivilotti
Journal:  Curr Opin Physiol       Date:  2019-06-12

3.  Heteromeric Neuronal Nicotinic Acetylcholine Receptors with Mutant β Subunits Acquire Sensitivity to α7-Selective Positive Allosteric Modulators.

Authors:  Clare Stokes; Sumanta Garai; Abhijit R Kulkarni; Lucas N Cantwell; Colleen M Noviello; Ryan E Hibbs; Nicole A Horenstein; Khalil A Abboud; Ganesh A Thakur; Roger L Papke
Journal:  J Pharmacol Exp Ther       Date:  2019-06-07       Impact factor: 4.030

4.  Intrinsically low open probability of α7 nicotinic acetylcholine receptors can be overcome by positive allosteric modulation and serum factors leading to the generation of excitotoxic currents at physiological temperatures.

Authors:  Dustin K Williams; Can Peng; Matthew R Kimbrell; Roger L Papke
Journal:  Mol Pharmacol       Date:  2012-07-24       Impact factor: 4.436

5.  A distinct mechanism for activating uncoupled nicotinic acetylcholine receptors.

Authors:  Corrie J B daCosta; Lopamudra Dey; J P Daniel Therien; John E Baenziger
Journal:  Nat Chem Biol       Date:  2013-09-08       Impact factor: 15.040

Review 6.  Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Biochem Pharmacol       Date:  2011-05-14       Impact factor: 5.858

7.  Characterizing functional α6β2 nicotinic acetylcholine receptors in vitro: mutant β2 subunits improve membrane expression, and fluorescent proteins reveal responsive cells.

Authors:  Cheng Xiao; Rahul Srinivasan; Ryan M Drenan; Elisha D W Mackey; J Michael McIntosh; Henry A Lester
Journal:  Biochem Pharmacol       Date:  2011-05-17       Impact factor: 5.858

8.  Isoform-specific mechanisms of α3β4*-nicotinic acetylcholine receptor modulation by the prototoxin lynx1.

Authors:  Andrew A George; Abigail Bloy; Julie M Miwa; Jon M Lindstrom; Ronald J Lukas; Paul Whiteaker
Journal:  FASEB J       Date:  2017-01-18       Impact factor: 5.191

Review 9.  Merging old and new perspectives on nicotinic acetylcholine receptors.

Authors:  Roger L Papke
Journal:  Biochem Pharmacol       Date:  2014-01-31       Impact factor: 5.858

Review 10.  Molecular mechanisms of acetylcholine receptor-lipid interactions: from model membranes to human biology.

Authors:  John E Baenziger; Corrie J B daCosta
Journal:  Biophys Rev       Date:  2012-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.